Yatharth Hospital & Trauma Care Services Ltd
NSE: YATHARTH BSE: 543950Healthcare
Incorporated in 2008, Yatharth Hospital and Trauma Care Services Limited is a multi-care hospitals at Noida, Greater Noida, and Noida Extension, Uttar Pradesh.[1]
₹813
52W: ₹485 — ₹888
PE 83.8 · Book ₹163 · +399% vs bookMarket Cap₹7,834 Cr
Stock P/E83.8Price to Earnings
ROCE10.1%Return on Capital
ROE7.25%Return on Equity
Div. Yield0%Face Value ₹10
Strengths
- +Company is almost debt free.
- +Company has delivered good profit growth of 155% CAGR over last 5 years
Weaknesses
- −Though the company is reporting repeated profits, it is not paying out dividend
- −Company has a low return on equity of 12.8% over last 3 years.
- −Working capital days have increased from 337 days to 551 days
Shareholding Pattern
Promoters55.8%
FIIs5.25%
DIIs12%
Public26.94%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 66.54% | 66.54% | 61.44%▼5.1 | 61.64%▲0.2 | 61.64% | 61.64% | 55.8%▼5.8 | 55.8% |
| FIIs | 4.9% | 6.28%▲1.4 | 9.78%▲3.5 | 4.45%▼5.3 | 4.34%▼0.1 | 6.51%▲2.2 | 6.18%▼0.3 | 5.25%▼0.9 |
| DIIs | 9.4% | 6.97%▼2.4 | 11.5%▲4.5 | 13.56%▲2.1 | 13.52%▼0.0 | 8.71%▼4.8 | 11.02%▲2.3 | 12%▲1.0 |
| Public | 19.16% | 20.2%▲1.0 | 17.27%▼2.9 | 20.35%▲3.1 | 20.5%▲0.1 | 23.16%▲2.7 | 27.01%▲3.9 | 26.94%▼0.1 |
Financial Statements
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 110 | 102 | 106 | 119 | 113 | 110 | 112 | 130 | 137 | 158 |
| Expenses | 79 | 72 | 78 | 86 | 82 | 79 | 80 | 95 | 110 | 122 |
| Operating Profit | 31 | 29 | 28 | 33 | 31 | 32 | 32 | 35 | 27 | 37 |
| OPM % | 28% | 29% | 26% | 28% | 27% | 29% | 28% | 27% | 20% | 23% |
| Net Profit | 21 | 21 | 26 | 23 | 20 | 22 | 22 | 27 | 21 | 24 |
| EPS ₹ | 2.45 | 2.46 | 3.06 | 2.7 | 2.38 | 2.31 | 2.27 | 2.81 | 2.14 | 2.48 |
AI Insights
Revenue Trend
TTM revenue at ₹538Cr, up 21.7% YoY. OPM at 24%.
Debt Position
Borrowings at ₹6Cr. Debt-to-equity ratio: 0.00x. Healthy balance sheet.
Capex Cycle
CWIP at ₹12Cr (3% of fixed assets). Moderate ongoing capital expenditure.
Institutional Flow
DIIs: 12% (+3.12pp change). FIIs: 5.25% (-0.17pp change). Promoters hold 55.8%.
Margin & Efficiency
ROCE improving from 0% (Mar 2017) to 10% (Mar 2025). Working capital days: 551.
Valuation
PE 83.8x with 10.1% ROCE. Price is 399% above book value of ₹163. Dividend yield: 0%.
Recent Announcements
- Board Meeting Intimation for Audited Financial Results For The Quarter And Financial Year Ended On March 31, 2026. 5m - Board meeting on May 25, 2026 to approve FY26 audited standalone and consolidated results.
- Announcement under Regulation 30 (LODR)-Monitoring Agency Report 14 May - Crisil’s March 31, 2026 QIP monitoring report notes a Rs 0.46 million deviation, rectified during the quarter.
- Announcement under Regulation 30 (LODR)-Monitoring Agency Report 14 May - CARE report for quarter ended Mar 31, 2026 shows no deviation, but delays in IPO utilization.
- Voting Results Of Postal Ballot 14 May - Shareholders approved creation of security by charge/mortgage/hypothecation through postal ballot on May 12, 2026.
- Shareholder Meeting / Postal Ballot-Scrutinizer"s Report 14 May
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse